RGNT
Regentis Biomaterials is a tissue repair company that develops and commercializes an innovative hydrogel platform for repairing damaged tissue. Its current focus is on orthopedic treatments using resorbable hydrogel implants to regenerate diseased or damaged tissue. The company is privately held with headquarters in Or Akiva, Israel, backed by a diverse group of investors, and adheres to high manufacturing standards including GMP and ISO 13485.
No recent news for this company.
No recent deals for this company.